Reasons for nonadherence and response to treatment in an adherence intervention trial for relapsing-remitting multiple sclerosis patients

ObjectivesTo explore whether patients in an adherence trial who appeared not to take disease modifying therapy (DMT) for avoidance reasons could be reliably identified, by observational coding, for their main reason of not taking DMT. To determine whether reason groups could be distinguished by clinical and self-report psychological characteristics and intervention outcomes. MethodParticipants were multiple sclerosis patients (N=78, 88.5% female, mean age 45.64) demotivated to take DMT. Audio recordings of the sessions were coded for the main reason of not taking DMT. Reason groups were compared based on patient characteristics and intervention outcomes. ResultsAvoidance and three other reasons for not taking DMT (side effects, cost, and mild course) were reliably identified (=0.88). Patient characteristics failed to distinguish participants in the Avoidance group, which also had poorer outcomes (X-2 [2, n=73]=6.35, p=0.036). ConclusionsPatients not taking DMT for avoidance reasons may need novel methods to identify them and encourage (re-)initiation.